| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2003105605A3 Use of pullulan as a slowly digested carbohydrate |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003103603A3 Novel formate salt of o-desmethyl-venlafaxine |
| 03/25/2004 | WO2003090726A3 Chewable soft capsule |
| 03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003083064A3 Chimeric pancreas |
| 03/25/2004 | WO2003082271A3 Indole derivatives having anti-angiogenetic activity |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003066647A3 Synthesis of inositolphosphate glycan molecules: treatment of cell proliferation disorders and metabolic disorders characterized by insulin resistance |
| 03/25/2004 | WO2003059372A3 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 03/25/2004 | WO2003048195A3 Glucose dependant release of insulin from glucose sensing insulin derivatives |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003016351A3 N - cam related compounds modulating cell groth |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | WO2002092756A8 Insulin producing cells derived from human embryonic stem cells |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002051433A3 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | US20040059142 Combining a crude arachidonic acid(ARA) a polyunsaturated fatty acids (PUFAs) containing oil with a crude DHA OR EPA(docosahexaenoic acid or eicosapentaenoic acid) containing oil, purifying to produce purified ARA, DHA or EPA |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059065 Polymer containing amino or imino groups crosslinked by a compound having a vinyl group that reacts by michael addition reaction or a carboxy ester group; medicinal phosphorus adsorbers |
| 03/25/2004 | US20040058987 Hypotensive agents; oxidation resistance, nitrogen scavenger; anticancer agents; antiischemic agents |
| 03/25/2004 | US20040058986 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058965 Alkanoic acid derivatives process for their production and use thereof |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058940 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/25/2004 | US20040058936 Dietetics, sexual disorders, antidiabetic agents |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058925 Method of treating fibromyalgia and other somatoform disorders |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058921 Psychological disorders; antidepressants; sexual disorders ; eating disorders |
| 03/25/2004 | US20040058920 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058908 Mixture of bile acid transport inhibitor, cholesteryl ester transport protein inhibitor, fibric acid, nicotinic acid, microsomal triglyceride transfer protein inhibitor and sterols |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058904 Antiinflammatory agents; autoimmune disease |
| 03/25/2004 | US20040058903 Anticholesterol agents; cardiovascular disorders |
| 03/25/2004 | US20040058892 Antidiabetic agents |
| 03/25/2004 | US20040058890 Replacement fir carbohydrates, fats; dietetics; therapy for non-insulin dependent diabetes |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058868 Using insulin receptor substrate and histone deacetylase inhibitor; regenerating insulin sensitivity |
| 03/25/2004 | US20040058867 Management of the consequences of fetal programming |
| 03/25/2004 | US20040058854 Synergistc therapy; bioavailability |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058024 Comprises polyunsaturated fatty acid-containing composition extracted from Echium plants, with antilipemic agents, antioxidants, and antidiabetic agents, for formulation as dietary supplement |
| 03/25/2004 | US20040058022 Method for producing fat and /or solids from beans and compositions containing polyphenols |
| 03/25/2004 | US20040058005 Comprises polyvinylpyrrolidone; for improved bioavailability/ dissolution |
| 03/25/2004 | US20040058004 Suspensions of micronized fenofibrate |
| 03/25/2004 | US20040057999 Fenofibrate compositions having enhanced bioavailability |
| 03/25/2004 | US20040057998 Granulates of micronized fenofibrate; high bioavailability through improved dissolution |
| 03/25/2004 | US20040057997 Capsules containing fenofibrate compositions |
| 03/25/2004 | US20040057992 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms |
| 03/25/2004 | US20040057964 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040056240 Adhesive |
| 03/25/2004 | CA2498739A1 Immunization against autologous ghrelin |
| 03/25/2004 | CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 03/25/2004 | CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/25/2004 | CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/25/2004 | CA2489405A1 Screening method of agents for increasing insulin content |
| 03/24/2004 | EP1400576A1 Adhesive |
| 03/24/2004 | EP1400529A1 Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1400246A1 Oral compositions for the treatment of obese, non-diabetic mammals, including humans |
| 03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 03/24/2004 | EP1399531A1 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 03/24/2004 | EP1399469A2 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |